Abstract
Background The relationship between maternal risk factors (MRFs) (particularly pre-gravid obesity, diabetes, and hypertension) and congenital heart disease (CHD) to placental and fetal brain outcomes is poorly understood. Here, we tested the hypothesis that MRF and CHD would be associated with reduced intrinsic placental and fetal brain function using a novel non-invasive technique.
Methods Pregnant participants with and without MRF and fetal CHD were prospectively recruited and underwent feto-placental MRI. Using intrinsic properties of blood oxygen level dependent imaging (BOLD) we quantified spatiotemporal variance of placenta and fetal brain. MRFs and CHD were correlated with functional characteristics of the placenta and fetal brain.
Results Co- morbid MRF (hypertension, diabetes, and obesity) reduced spatiotemporal functional variance of placenta and fetal brain (p < 0.05). CHD predicted reduced fetal brain temporal variance compared to controls (p<0.05). Interaction of MRF and CHD status was associated with reduced intrinsic pBOLD temporal variance (p=0.047). There were no significant interactions of MRFs and CHD status on either temporal or spatial variance of intrinsic brain BOLD.
Conclusion MRF and CHD reduced functional characteristic of placenta and brain in fetuses. MRF modification and management during pregnancy may have the potential to not only provide additional risk stratification but may also improve neurodevelopmental outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Department of Defense (W81XWH-16-1-0613) The National Heart, Lung and Blood Institute (R01 HL152740-1, R01 HL128818-05) The National Heart, Lung and Blood Institute with National Institute on Aging (R01HL128818-05 S1). Southern California Clinical and Translational Sciences Institute (NCATS) through Grant UL1TR0001855. Additional Ventures for support (AP, VR, RC) VR is supported by the Saban Research Institute, Additional Ventures Foundation and NIH-NHLBI K01HL153942.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Pittsburgh Institutional Review Board, Pittsburgh, PA, USA gave ethical approval for this work. STUDY20030213
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding support: This work was supported by the Department of Defense (W81XWH-16-1-0613), the National Heart, Lung and Blood Institute (R01 HL152740-1, R01 HL128818-05), and the National Heart, Lung and Blood Institute with National Institute on Aging (R01HL128818-05 S1). Southern California Clinical and Translational Sciences Institute (NCATS) through Grant UL1TR0001855. We also acknowledge Additional Ventures for support (AP, VR, RC) VR is supported by the Saban Research Institute, Additional Ventures Foundation and NIH-NHLBI K01HL153942.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- MRI
- magnetic resonance imaging
- CHD
- congenital heart disease
- MRF
- maternal risk factors
- pBOLD
- placental Blood Oxygen Level Dependent MRI
- brain BOLD
- fetal brain resting Blood Oxygen Level Dependent MRI
- GA
- gestational age
